Primary |
Drug Use For Unknown Indication |
33.9% |
Cataract Operation |
16.1% |
Anaesthesia |
7.8% |
Local Anaesthesia |
7.8% |
Intentional Overdose |
7.3% |
Cycloplegia |
3.6% |
Off Label Use |
3.6% |
Medication Dilution |
2.6% |
Preoperative Care |
2.6% |
Mydriasis |
2.1% |
Pupil Dilation Procedure |
2.1% |
Perioperative Analgesia |
1.6% |
Retinopathy Of Prematurity |
1.6% |
Bladder Disorder |
1.0% |
Epilepsy |
1.0% |
Hypotension |
1.0% |
Nasopharyngitis |
1.0% |
Osteoarthritis |
1.0% |
Postoperative Care |
1.0% |
Spinal Anaesthesia |
1.0% |
|
Pulmonary Oedema |
12.1% |
Visual Acuity Reduced |
12.1% |
Rhabdomyolysis |
9.1% |
Drug Eruption |
6.1% |
Pupil Fixed |
6.1% |
Retinal Injury |
6.1% |
Tachycardia |
6.1% |
Wrong Drug Administered |
6.1% |
Bradycardia |
3.0% |
Confusional State |
3.0% |
Crepitations |
3.0% |
Drug Ineffective |
3.0% |
Drug Interaction |
3.0% |
Foetal Exposure During Pregnancy |
3.0% |
Hallucination, Visual |
3.0% |
Headache |
3.0% |
Hypertension |
3.0% |
Infusion Site Reaction |
3.0% |
Medication Error |
3.0% |
Myocardial Infarction |
3.0% |
|
Secondary |
Cataract Operation |
16.8% |
Intentional Overdose |
14.2% |
Product Used For Unknown Indication |
14.2% |
Preoperative Care |
13.8% |
Postoperative Care |
5.9% |
Drug Use For Unknown Indication |
5.1% |
Hypotension |
4.7% |
Anaesthesia |
4.5% |
Eye Irrigation |
4.3% |
Perioperative Analgesia |
3.8% |
Analgesia |
2.5% |
Ophthalmological Examination |
1.4% |
Cerebral Hypoperfusion |
1.3% |
Convulsion |
1.2% |
Maintenance Of Anaesthesia |
1.2% |
Prophylaxis |
1.2% |
Eye Operation |
1.0% |
Nausea |
1.0% |
Premedication |
1.0% |
Intracranial Pressure Increased |
0.9% |
|
Toxic Anterior Segment Syndrome |
31.3% |
Rhabdomyolysis |
16.7% |
Endophthalmitis |
6.3% |
Hypotension |
4.2% |
Propofol Infusion Syndrome |
4.2% |
Rash Erythematous |
4.2% |
Respiratory Arrest |
3.1% |
Toxicity To Various Agents |
3.1% |
Visual Acuity Reduced |
3.1% |
Vomiting |
3.1% |
Device Failure |
2.1% |
Drug Ineffective |
2.1% |
Incisional Hernia |
2.1% |
Intentional Overdose |
2.1% |
Laboratory Test Abnormal |
2.1% |
Necrotising Colitis |
2.1% |
Pulmonary Oedema |
2.1% |
Respiratory Acidosis |
2.1% |
Stress Cardiomyopathy |
2.1% |
Suicide Attempt |
2.1% |
|
Concomitant |
Drug Use For Unknown Indication |
51.5% |
Product Used For Unknown Indication |
23.0% |
Pain |
3.0% |
Hypertension |
2.2% |
Hypotension |
1.9% |
Cataract Operation |
1.8% |
Anaesthesia |
1.7% |
Prophylaxis |
1.6% |
Myocardial Infarction |
1.5% |
Sedation |
1.5% |
Mydriasis |
1.3% |
Coronary Artery Bypass |
1.2% |
Nausea |
1.2% |
Chronic Myeloid Leukaemia |
1.1% |
Induction Of Anaesthesia |
1.0% |
Premedication |
1.0% |
Catheterisation Cardiac |
1.0% |
Ill-defined Disorder |
0.9% |
Local Anaesthesia |
0.9% |
Preoperative Care |
0.9% |
|
Floppy Iris Syndrome |
18.5% |
Thrombocytopenia |
10.1% |
Tachycardia |
6.9% |
Toxic Anterior Segment Syndrome |
6.3% |
Weight Decreased |
6.3% |
Vomiting |
5.8% |
Pain |
4.2% |
Hypotension |
3.7% |
Renal Failure Acute |
3.7% |
Respiratory Failure |
3.7% |
Sepsis |
3.7% |
Upper Respiratory Tract Infection |
3.7% |
Syncope |
3.2% |
Tracheostomy |
3.2% |
Unresponsive To Stimuli |
3.2% |
Ventricular Tachycardia |
3.2% |
Fear |
2.6% |
Miosis |
2.6% |
Multi-organ Failure |
2.6% |
Pyrexia |
2.6% |
|
Interacting |
Induction Of Anaesthesia |
20.0% |
Parkinson's Disease |
15.0% |
Retinoblastoma |
15.0% |
Allergy Prophylaxis |
10.0% |
Bronchospasm |
5.0% |
Contrast Media Allergy |
5.0% |
Imaging Procedure |
5.0% |
Ophthalmological Examination |
5.0% |
Product Used For Unknown Indication |
5.0% |
Prophylaxis |
5.0% |
Thrombosis Prophylaxis |
5.0% |
Vasoconstriction |
5.0% |
|
Drug Interaction |
25.0% |
Inhibitory Drug Interaction |
25.0% |
Potentiating Drug Interaction |
25.0% |
Vasospasm |
25.0% |
|